These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 22922040)

  • 1. Phase I/II study of radiologic hepatic arterial infusion of fluorouracil plus systemic irinotecan for unresectable hepatic metastases from colorectal cancer: Japan Clinical Oncology Group Trial 0208-DI.
    Arai Y; Ohtsu A; Sato Y; Aramaki T; Kato K; Hamada M; Muro K; Yamada Y; Inaba Y; Shimada Y; Boku N; Takeuchi Y; Morita S; Satake M
    J Vasc Interv Radiol; 2012 Oct; 23(10):1261-7. PubMed ID: 22922040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.
    Kemeny N; Jarnagin W; Paty P; Gönen M; Schwartz L; Morse M; Leonard G; D'Angelica M; DeMatteo R; Blumgart L; Fong Y
    J Clin Oncol; 2005 Aug; 23(22):4888-96. PubMed ID: 16009951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination chemotherapy with hepatic arterial infusion of 5-fluorouracil (5-FU) and systemic irinotecan (CPT-11) in patients with unresectable liver metastases from colorectal cancer].
    Shitara K; Munakata M; Kudo T; Kasai M; Muto O; Okada R; Mitobe S; Ishiguro A; Sakuraba H; Ikami I; Sakata Y
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):2033-7. PubMed ID: 17197748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-arterial therapies for colorectal cancer liver metastases (radioembolization excluded).
    de Baere T; Tselikas L; Boige V; Ducreux M; Malka D; Goéré D; Benahim E; Deschamps F
    Bull Cancer; 2017 May; 104(5):402-406. PubMed ID: 27993355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and safety of hepatic arterial infusion of oxaliplatin plus intravenous irinotecan, leucovorin and fluorouracil in colorectal cancer with inoperable hepatic metastasis.
    Volovat SR; Volovat C; Negru SM; Danciu M; Scripcariu V
    J Chemother; 2016 Jun; 28(3):235-41. PubMed ID: 26018108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic Arterial Infusion Chemotherapy for Life Threatening Patients due to Liver Metastases from Colorectal Cancer with Cetuximab.
    Yoshimatsu K; Osawa G; Yokomizo H; Yano Y; Nakayama M; Okayama S; Matsumoto A; Fujimoto T; Morita S; Naritaka Y
    Hepatogastroenterology; 2015 May; 62(139):612-4. PubMed ID: 26897939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic artery infusion therapy is effective for chemotherapy-resistant liver metastatic colorectal cancer.
    Goi T; Naruse T; Kimura Y; Fujimoto D; Morikawa M; Koneri K; Yamaguchi A
    World J Surg Oncol; 2015 Oct; 13():296. PubMed ID: 26452624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic Arterial Infusion Chemotherapy of 5-Fluorouracil for Patients with Unresectable Liver Metastases from Colorectal Cancer Refractory to Standard Systemic Chemotherapy: A Multicenter Retrospective Study.
    Sato Y; Inaba Y; Aramaki T; Sone M; Morita Y; Nishiofuku H; Tanaka T; Miyazaki M; Matsueda K; Arai Y
    Oncology; 2020; 98(5):267-272. PubMed ID: 32092755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of a Phase I/II Trial of Hepatic Arterial Infusion of Oxaliplatin Combined with Intravenous 5-Fluorouracil and l-Leucovorin in Patients with Unresectable Liver Metastases from Colorectal Cancer After Systemic Chemotherapy Failure.
    Sato Y; Inaba Y; Ura T; Nishiofuku H; Yamaura H; Kato M; Takahari D; Tanaka T; Muro K
    J Gastrointest Cancer; 2018 Jun; 49(2):132-137. PubMed ID: 28058527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I/II study of irinotecan, UFT and leucovorin with hepatic arterial infusion using 5-FU in colorectal cancer patients with unresectable liver metastases.
    Yamaguchi T; Matsumoto H; Yasutome M; Mori T; Takahashi K
    Cancer Chemother Pharmacol; 2011 Mar; 67(3):629-35. PubMed ID: 20495917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases.
    Guan M; Chen SC; Ying HY; Zhao L; Li XY; Zhou JF; Shao YJ; Yang XD; Lin Y; Ning XH; Bai CM
    Chin Med J (Engl); 2012 Oct; 125(20):3640-5. PubMed ID: 23075717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy.
    van Hazel GA; Pavlakis N; Goldstein D; Olver IN; Tapner MJ; Price D; Bower GD; Briggs GM; Rossleigh MA; Taylor DJ; George J
    J Clin Oncol; 2009 Sep; 27(25):4089-95. PubMed ID: 19652069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatic arterial infusion chemotherapy for liver metastases from colorectal cancer].
    Arai Y; Matsueda K; Inaba Y
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2193-200. PubMed ID: 11142162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic arterial infusion chemotherapy through a port-catheter system as preoperative initial therapy in patients with advanced liver dysfunction due to synchronous and unresectable liver metastases from colorectal cancer.
    Iguchi T; Arai Y; Inaba Y; Yamaura H; Sato Y; Miyazaki M; Shimamoto H
    Cardiovasc Intervent Radiol; 2008; 31(1):86-90. PubMed ID: 17926088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Toxicity of Hepatic Intra-Arterial Drug-Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan-Refractory Unresectable Colorectal Liver Metastases.
    Bhutiani N; Akinwande O; Martin RC
    World J Surg; 2016 May; 40(5):1178-90. PubMed ID: 26711640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer.
    Kemeny N; Jarnagin W; Gonen M; Stockman J; Blumgart L; Sperber D; Hummer A; Fong Y
    J Clin Oncol; 2003 Sep; 21(17):3303-9. PubMed ID: 12947066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal therapy with intravenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in non-resectable hepatic metastases from colorectal cancer (a European Association for Research in Oncology trial).
    Zelek L; Bugat R; Cherqui D; Ganem G; Valleur P; Guimbaud R; Dupuis O; Aziza T; Fagniez PL; Auroux J; Kobeiter H; Tayar C; Braud AC; Haddad E; Piolot A; Buyse M; Piedbois P;
    Ann Oncol; 2003 Oct; 14(10):1537-42. PubMed ID: 14504055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined systemic chronotherapy and hepatic artery infusion for the treatment of metastatic colorectal cancer confined to the liver.
    Shimonov M; Hayat H; Chaitchik S; Brener J; Schachter P; Czerniak A
    Chemotherapy; 2005 May; 51(2-3):111-5. PubMed ID: 15886466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of UFT with leucovorin plus hepatic arterial infusion with irinotecan, 5-fluorouracil and leucovorin for non-resectable liver metastases of colorectal cancer.
    Idelevich E; Greif F; Mavor E; Miller R; Kashtan H; Susmalian S; Ariche A; Brenner B; Baruch NB; Dinerman M; Shani A
    Chemotherapy; 2009; 55(2):76-82. PubMed ID: 19077422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic arterial infusion chemotherapy prior to standard systemic chemotherapy in patients with highly advanced unresectable liver metastases from colorectal cancer: a report of three patients.
    Iguchi T; Idani H; Asami S; Endo H; Inaba Y; Arai Y; Kanazawa S
    Acta Med Okayama; 2011 Feb; 65(1):49-53. PubMed ID: 21339796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.